BioSpace News Archive

Business

OMNIVISION and AdaptivEndo Partner to Provide a Unified Platform for Hybrid and Single-Use Flexible Endoscopes

OMNIVISION and AdaptivEndo™ today announced their partnership to provide a flexible, unified platform for hybrid and single-use endoscopes, including systems used for gastroenterology, hepatology, urology, gynecology, and advanced endoscopic surgery (spinal and cardiac electrophysiology).

October 31, 2022
·
4 min read
Business

Lineage Cell Therapeutics Appoints Jill Howe as Chief Financial Officer

Lineage Cell Therapeutics, Inc. announced today that Jill Howe will join as the Company’s Chief Financial Officer, effective November 14, 2022.

October 31, 2022
·
6 min read
Biotech Bay

Sagimet Biosciences Announces Late-Breaking, Oral and Poster Presentations for Denifanstat (TVB-2640), a First-in-Class Fatty Acid Synthase Inhibitor, in NASH at AASLD’s The Liver Meeting

Sagimet Biosciences announced today that it will present three abstracts at The Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place November 4-8, 2022, in Washington, DC.

October 31, 2022
·
3 min read
Drug Development

Verge Genomics Initiates First-In-Human Dosing in Phase 1 Trial of VRG50635, a Novel Therapeutic for Amyotrophic Lateral Sclerosis

Verge Genomics announced today that the first subject has been dosed in a Phase 1 clinical trial of VRG50635. VRG50635 is a small molecule inhibitor of PIKfyve, a novel therapeutic target for amyotrophic lateral sclerosis (ALS) discovered by CONVERGETM, Verge’s all-in-human, AI-powered platform.

October 31, 2022
·
4 min read
FDA

Aulos Bioscience Announces FDA Clearance of IND Application for AU-007, a Novel Immunotherapy for the Treatment of Solid Tumors

Aulos Bioscience today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for AU-007, a monoclonal antibody computationally designed by Biolojic Design.

October 31, 2022
·
3 min read
FDA

Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure

Abiomed (Nasdaq: ABMD) announces that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s highest level of approval, as safe and effective to treat acute right heart failure for up to 14 days.

October 31, 2022
·
4 min read
Business

Miravo Healthcare™ Announces Third Quarter 2022 Results Release Date and Conference Call Details

Nuvo Pharmaceuticals Inc. today announced it expects to release its third quarter 2022 financial results before markets open on Monday, November 14, 2022.

October 31, 2022
·
1 min read
Deals

Thermo Fisher Scientific to Acquire The Binding Site Group

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”).

October 31, 2022
·
8 min read
Drug Development

KalVista Pharmaceuticals Announces Positive Phase 1 Data for Orally Disintegrating Tablet Formulation of Sebetralstat for Use in Hereditary Angioedema

KalVista Pharmaceuticals, Inc. today announced positive phase 1 data for an orally disintegrating tablet (ODT) formulation for its lead compound sebetralstat.

October 31, 2022
·
4 min read
Business

Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment.

October 31, 2022
·
4 min read